Instrument Inactif

Communiqués LA JOLLA PHARM Other OTC

Actions

Recherche biotechnologique et médicale

Cours en clôture Other OTC Autres places de cotation
- ^USD	-

22/08/22	La Jolla Pharmaceutical annonce des changements de direction	CI
22/08/22	Innoviva, Inc. (NasdaqGS:INVA) a finalisé l'acquisition de La Jolla Pharmaceutical Company (NasdaqCM:LJPC).	CI

Communiqués

22/08/22	La Jolla Pharmaceutical : Termination of a Material Definitive Agreement - Form 8-K	PU
22/08/22	LA JOLLA PHARMACEUTICAL CO : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	AQ
15/08/22	LA JOLLA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
12/07/22	LA JOLLA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of La Jolla Pharmaceutical Company - LJPC	BU
11/07/22	Twitter, Las Vegas Sands fall; Mullen, La Jolla rise	AQ
11/07/22	La Jolla Pharmaceutical : Innoviva to Acquire La Jolla Pharmaceutical Company - Form 8-K	PU
11/07/22	LA JOLLA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
11/07/22	Innoviva to Acquire La Jolla Pharmaceutical Company	BU
16/05/22	La Jolla Pharmaceutical: Q1 Earnings Snapshot	AQ
16/05/22	LA JOLLA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
16/05/22	La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Corporate Progress	BU
17/03/22	La Jolla Pharmaceutical : Corporate Presentation March 2022	PU
09/03/22	La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2021 and Highlights Corporate Progress	BU
09/03/22	LA JOLLA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ
16/02/22	LA JOLLA PHARMACEUTICAL CO : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
18/11/21	La Jolla Pharmaceutical : Announces Share Repurchase Plan - Form 8-K	PU
18/11/21	LA JOLLA PHARMACEUTICAL CO : Other Events, Financial Statements and Exhibits (form 8-K)	AQ
17/11/21	La Jolla Pharmaceutical Company Announces Share Repurchase Plan	BU
05/11/21	La Jolla Corporate Presentation November 2021	PU
04/11/21	La Jolla Pharmaceutical: Q3 Earnings Snapshot	AQ
04/11/21	La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2021 and Highlights Corporate Progress	BU
04/11/21	LA JOLLA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
10/09/21	La Jolla Pharmaceutical : Tony Hodges, M.D., FACP, FCCP, Appointed Chief Medical Officer of La Jolla Pharmaceutical Company	PU
11/08/21	La Jolla Pharmaceutical : Corporate Presentation August 2021	PU
05/08/21	La Jolla Pharmaceutical: Q2 Earnings Snapshot	AQ